Molecular measurement of BCR-ABL transcript variations in chronic myeloid leukemia patients in cytogenetic remission

BACKGROUND: The monitoring of BCR-ABL transcript levels by real-time quantitative polymerase chain reaction (RT-qPCR) has become important to assess minimal residual disease (MRD) and standard of care in the treatment of chronic myeloid leukemia (CML). In this study, we performed a prospective, sequ...

Descripción completa

Detalles Bibliográficos
Autores principales: Serpa, Mariana, Sanabani, Sabri S, Dorliac-Llacer, Pedro Enrique, Conchon, Monika, Pereira, Thales Dalessandro Meneguin, Nardinelli, Luciana, Costa, Juliana Lima, Novaes, Mafalda Megumi Yoshinaga, Ferreira, Patricia de Barros, Bendit, Israel
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2995483/
https://www.ncbi.nlm.nih.gov/pubmed/21087500
http://dx.doi.org/10.1186/1471-2326-10-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2995483/
https://www.ncbi.nlm.nih.gov/pubmed/21087500
http://dx.doi.org/10.1186/1471-2326-10-7

Ejemplares similares